1-18 of 18
Craig L. Slingluff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT073: Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038

Antoni Ribas, Salvador Martín-Algarra, Shailender Bhatia, Wen-Jen Hwu, Craig L. Slingluff, William H. Sharfman, F. Stephen Hodi, Walter J. Urba, Jason J. Luke, John B. Haanen, Margaret K. Callahan, Jedd D. Wolchok, Scott D. Chasalow, Petra Ross-Macdonald, Tina C. Young, Anila Qureshi, Christine E. Horak
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT073.
https://doi.org/10.1158/1538-7445.AM2017-CT073
Published: 01 July 2017
View article titled, Abstract CT073: Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038
Journal Articles

Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab

Timothy A. Chan, Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Jennifer S. Sims, F. Stephen Hodi, Salvador Martín-Algarra, William H. Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Sviatoslav M. Kendall, Han Chang, John-William Sidhom, Jonathan P. Schneck, Nils Weinhold, Christine E. Horak, Walter J. Urba
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2988.
https://doi.org/10.1158/1538-7445.AM2017-2988
Published: 01 July 2017
View article titled, Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab
Journal Articles

Abstract 2855: Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma

Walter J. Urba, Salvador Martín-Algarra, Margaret Callahan, Jedd D. Wolchok, William H. Sharfman, Jeffrey A. Sosman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Yun Shen, Christine E. Horak, F Stephen Hodi
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2855.
https://doi.org/10.1158/1538-7445.AM2015-2855
Published: 01 August 2015
View article titled, Abstract 2855: Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma
Journal Articles

Abstract 1780: Targeted inactivation of CRL4-CDT2 E3 ubiquitin ligase as a novel therapeutic strategy for malignant melanoma

Mouadh Benamar, Fadila Guessous, Patrick Corbett, Craig L. Slingluff, Tarek Abbas
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1780.
https://doi.org/10.1158/1538-7445.AM2015-1780
Published: 01 August 2015
View article titled, Abstract 1780: Targeted inactivation of CRL4-CDT2 E3 ubiquitin ligase as a novel therapeutic strategy for malignant melanoma
Journal Articles

Abstract CT220: A randomized multicenter phase Ib/II study to assess the safety and the immunological effect of chemoradiation therapy (CRT) in combination with Pembrolizumab (anti-PD1) to CRT alone in patients with resectable or borderline resectable pancreatic canc

Matthew H.G Katz, Todd W. Bauer, Gauri Rajani Varadhachary, Reid B. Adams, Amy R. Lankford, Gina Petroni, Timothy N. Bullock, Craig L. Slingluff, Osama E. Rahma
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT220.
https://doi.org/10.1158/1538-7445.AM2015-CT220
Published: 01 August 2015
View article titled, Abstract CT220: A randomized multicenter phase Ib/II study to assess the safety and the immunological effect of chemoradiation therapy (CRT) in combination with Pembrolizumab (anti-PD1) to CRT alone in patients with resectable or borderline resectable pancreatic canc
Journal Articles

MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer

Angela L. Zarling, Rebecca C. Obeng, A. Nicole Desch, Joel Pinczewski, Kara L. Cummings, Donna H. Deacon, Mark Conaway, Craig L. Slingluff, Jr, Victor H. Engelhard
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6784–6795.
https://doi.org/10.1158/0008-5472.CAN-14-0043
Published: 30 November 2014
View article titled, MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer
Open the PDF for MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 3638: Vaccine-draining lymph nodes of cancer patients for generating anticancer antibodies

Girja S. Shukla, Stephanie C. Pero, Yu-jing Sun, Chelsea L. Carman, Walter C. Olson, Craig L. Slingluff, David N. Krag
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3638.
https://doi.org/10.1158/1538-7445.AM2014-3638
Published: 01 October 2014
View article titled, Abstract 3638: Vaccine-draining lymph nodes of cancer patients for generating anticancer antibodies
Journal Articles

Abstract 1584: MHC-restricted phosphopeptides as broad-based immunotherapeutic targets for cancer

Angela L. Zarling, Rebecca C. Obeng, Kara L. Cummings, Ashley N. Desch, Ann M. English, Jennifer M. Cottine, Andrew Norris, Louis B. Brill, Donna H. Deacon, Mark Conaway, Jeffrey Shabanowitz, Donald F. Hunt, Craig L. Slingluff, Victor H. Engelhard
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1584.
https://doi.org/10.1158/1538-7445.AM2012-1584
Published: 15 April 2012
View article titled, Abstract 1584: MHC-restricted phosphopeptides as broad-based immunotherapeutic targets for cancer
Journal Articles

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma

Gulsun Erdag, Jochen T. Schaefer, Mark E. Smolkin, Donna H. Deacon, Sofia M. Shea, Lynn T. Dengel, James W. Patterson, Craig L. Slingluff, Jr
Journal: Cancer Research
Cancer Res (2012) 72 (5): 1070–1080.
https://doi.org/10.1158/0008-5472.CAN-11-3218
Published: 01 March 2012
View article titled, Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
Open the PDF for Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3827: Interferons induce CXCR3-cognate chemokine production by melanoma

Amanda T. Lucht, Eleanor Clancy-Thompson, Lynn T. Dengel, Robert M. Strieter, Craig L. Slingluff, David W. Mullins
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3827.
https://doi.org/10.1158/1538-7445.AM10-3827
Published: 15 April 2010
View article titled, Abstract 3827: Interferons induce CXCR3-cognate chemokine production by melanoma
Journal Articles

Abstract 3843: Rational selection of combinatorial therapeutic targets for melanoma identified by synthetic lethal screening with small molecule inhibitors

Devin G. Roller, Kerrington R. Molhoek, Craig L. Slingluff, Michael J. Weber, Daniel Gioeli
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3843.
https://doi.org/10.1158/1538-7445.AM10-3843
Published: 15 April 2010
View article titled, Abstract 3843: Rational selection of combinatorial therapeutic targets for melanoma identified by synthetic lethal screening with small molecule inhibitors
Journal Articles

Human Melanoma Cytolysis by Combined Inhibition of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2

Kerrington R. Molhoek, Heinrich Griesemann, Jianfen Shu, Jeffrey E. Gershenwald, David L. Brautigan, Craig L. Slingluff, Jr.
Journal: Cancer Research
Cancer Res (2008) 68 (11): 4392–4397.
https://doi.org/10.1158/0008-5472.CAN-07-5844
Published: 02 June 2008
View article titled, Human Melanoma Cytolysis by Combined Inhibition of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2
Open the PDF for Human Melanoma Cytolysis by Combined Inhibition of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 in another window
Journal Articles

CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III Disease

Irene M. Mullins, Craig L. Slingluff, Jae K. Lee, Courtney F. Garbee, Jianfen Shu, Sara G. Anderson, Melanie E. Mayer, William A. Knaus, David W. Mullins
Journal: Cancer Research
Cancer Res (2004) 64 (21): 7697–7701.
https://doi.org/10.1158/0008-5472.CAN-04-2059
Published: 01 November 2004
View article titled, CXC Chemokine Receptor 3 Expression by Activated CD8<sup>+</sup> T cells Is Associated with Survival in Melanoma Patients with Stage III Disease
Open the PDF for CXC Chemokine Receptor 3 Expression by Activated CD8<sup>+</sup> T cells Is Associated with Survival in Melanoma Patients with Stage III Disease in another window
Includes: Supplementary data
Journal Articles

Expression of CCR6 and CXCR3 by activated CD8+ T lymphocytes following immunotherapeutic vaccination correlates with enhanced survival

Irene M. Mullins, Craig L. Slingluff, Jr., Sara G. Anderson, Jae K. Lee, Melanie E. Mayer, William A. Knaus, David W. Mullins
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 323–324.
Published: 01 April 2004
View article titled, Expression of CCR6 and CXCR3 by activated CD8<sup>+</sup> T lymphocytes following immunotherapeutic vaccination correlates with enhanced survival
Journal Articles

Identification of Novel and Widely Expressed Cancer/Testis Gene Isoforms That Elicit Spontaneous Cytotoxic T-Lymphocyte Reactivity to Melanoma

Kevin T. Hogan, Michael A. Coppola, Christine L. Gatlin, Lee W. Thompson, Jeffrey Shabanowitz, Donald F. Hunt, Victor H. Engelhard, Mark M. Ross, Craig L. Slingluff, Jr.
Journal: Cancer Research
Cancer Res (2004) 64 (3): 1157–1163.
https://doi.org/10.1158/0008-5472.CAN-03-2209
Published: 10 February 2004
View article titled, Identification of Novel and Widely Expressed Cancer/Testis Gene Isoforms That Elicit Spontaneous Cytotoxic T-Lymphocyte Reactivity to Melanoma
Open the PDF for Identification of Novel and Widely Expressed Cancer/Testis Gene Isoforms That Elicit Spontaneous Cytotoxic T-Lymphocyte Reactivity to Melanoma in another window
Journal Articles

The Peptide Recognized by HLA-A68.2-restricted, Squamous Cell Carcinoma of the Lung-specific Cytotoxic T Lymphocytes Is Derived from a Mutated Elongation Factor 2 Gene

Kevin T. Hogan, Dominic P. Eisinger, Samuel B. Cupp, III, Kristen J. Lekstrom, Donna D. Deacon, Jeffrey Shabanowitz, Donald F. Hunt, Victor H. Engelhard, Craig L. Slingluff, Jr., Mark M. Ross
Journal: Cancer Research
Cancer Res (1998) 58 (22): 5144–5150.
Published: 01 November 1998
View article titled, The Peptide Recognized by HLA-A68.2-restricted, Squamous Cell Carcinoma of the Lung-specific Cytotoxic T Lymphocytes Is Derived from a Mutated <em>Elongation Factor 2</em> Gene
Open the PDF for The Peptide Recognized by HLA-A68.2-restricted, Squamous Cell Carcinoma of the Lung-specific Cytotoxic T Lymphocytes Is Derived from a Mutated <em>Elongation Factor 2</em> Gene in another window
Journal Articles

Cytotoxic T-Lymphocyte Response to Autologous Human Squamous Cell Cancer of the Lung: Epitope Reconstitution with Peptides Extracted from HLA-Aw68

Craig L. Slingluff, Jr., Andrea L. Cox, John M. Stover, Jr., Marcia M. Moore, Donald F. Hunt, Victor H. Engelhard
Journal: Cancer Research
Cancer Res (1994) 54 (10): 2731–2737.
Published: 01 May 1994
View article titled, Cytotoxic T-Lymphocyte Response to Autologous Human Squamous Cell Cancer of the Lung: Epitope Reconstitution with Peptides Extracted from HLA-Aw68
Open the PDF for Cytotoxic T-Lymphocyte Response to Autologous Human Squamous Cell Cancer of the Lung: Epitope Reconstitution with Peptides Extracted from HLA-Aw68 in another window
Journal Articles

Generation of Human Autologous Melanoma-specific Cytotoxic T-Cells Using HLA-A2-matched Allogeneic Melanomas

Nancy J. Crowley, Craig L. Slingluff, Jr., Timothy L. Darrow, Hilliard F. Seigler
Journal: Cancer Research
Cancer Res (1990) 50 (3): 492–498.
Published: 01 February 1990
View article titled, Generation of Human Autologous Melanoma-specific Cytotoxic T-Cells Using HLA-A2-matched Allogeneic Melanomas
Open the PDF for Generation of Human Autologous Melanoma-specific Cytotoxic T-Cells Using HLA-A2-matched Allogeneic Melanomas in another window